Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$371.1K
3 trades · 1 insiders
Net · 90d
$-371.1K
Insiders on file
47
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Gheuens Sarah | Chief Medical Officer | 113 | $0 | $4.13M | 2026-10-26 |
| Backstrom Jay T. | Director | 6 | $0 | $0 | 2026-07-08 |
| Viswanadhan Krishnan | Chief Strategy and Operations | 12 | $0 | $185.0K | 2026-06-18 |
| Milanova Tsveta | Chief Commercial Officer | 43 | $0 | $741.9K | 2026-06-18 |
| Burns James William | Chief Legal Officer | 87 | $0 | $2.10M | 2026-06-18 |
| Jones Cecilia | Chief Financial Officer | 58 | $0 | $895.7K | 2026-06-18 |
| Owen Catherine E. | Director | 18 | $0 | $0 | 2026-06-18 |
| Ballal Rahul D. | Director | 31 | $0 | $1.12M | 2026-06-18 |
| Scadden David | Director | 55 | $16.7K | $98.2K | 2026-06-18 |
| Ho Maykin | Director | 37 | $0 | $0 | 2026-06-18 |
| Smith Cynthia | Director | 22 | $0 | $0 | 2026-06-18 |
| Goff Brian | Chief Executive Officer | 69 | $0 | $5.41M | 2026-06-18 |
| FOUSE JACQUALYN A | Director | 60 | $1.25M | $1.14M | 2026-06-18 |
| Foster-Cheek Kaye I | Director | 56 | $0 | $2.24M | 2026-06-18 |
| CAPELLO JEFFREY D | Director | 18 | $0 | $0 | 2026-06-18 |
| Washburn Theodore James Jr. | Principal Accounting Officer | 72 | $0 | $1.06M | 2026-03-03 |
| Schenkein David P | Director | 267 | $250.0K | $62.27M | 2024-06-20 |
| Poddar Richa | Chief Commercial Officer | 16 | $0 | $0 | 2022-10-17 |
| Clancy Paul J | Director | 24 | $0 | $0 | 2022-06-21 |
| MARAGANORE JOHN | Director | 37 | $550.2K | $2.00M | 2022-06-21 |
| CLARK IAN T | Director | 18 | $0 | $0 | 2022-05-20 |
| Car Bruce | Chief Scientific Officer | 21 | $0 | $0 | 2022-03-01 |
| Biller Jonathan | Chief Legal Officer | 21 | $0 | $0 | 2022-03-01 |
| Alenson Carman | Principal Accounting Officer | 55 | $0 | $773.2K | 2021-06-21 |
| Bowden Christopher | Chief Medical Officer | 132 | $0 | $13.23M | 2021-06-18 |
| Miles Darrin | Chief Commercial Officer | 13 | $0 | $321.7K | 2021-05-14 |
| Hirsch Andrew | Chief Financial Officer | 28 | $0 | $0 | 2020-04-22 |
| Celgene Alpine Investment Co., LLC | 10% Owner | 2 | $69.53M | $0 | 2019-11-12 |
| Biller Scott | Chief Scientific Officer | 264 | $0 | $24.40M | 2019-06-11 |
| Hoerter Steven L. | Chief Commercial Officer | 42 | $0 | $3.75M | 2019-03-04 |
| CELGENE CORP /DE/ | 10% Owner | 7 | $100.69M | $0 | 2018-01-23 |
| Cantley Lewis Clayton Jr. | Director | 148 | $0 | $12.81M | 2017-12-07 |
| NELSEN ROBERT | Director, 10% Owner | 35 | $0 | $20.75M | 2017-03-06 |
| Cole Douglas G. | Director | 5 | $0 | $0 | 2016-08-10 |
| Tessier-Lavigne Marc | Director | 5 | $1000.0K | $0 | 2016-06-21 |
| Goddard Glenn | Senior Vice President, Finance | 113 | $0 | $9.86M | 2016-02-16 |
| Higgons John Duncan | Chief Operating Officer | 103 | $0 | $23.02M | 2016-01-04 |
| KARSEN PERRY A | Director | 2 | $0 | $0 | 2015-06-23 |
| Third Rock Ventures GP, L.P. | 10% Owner | 9 | $0 | $0 | 2015-02-19 |
| Arch Venture Fund VII LP | 10% Owner | 1 | $0 | $0 | 2015-02-19 |
| STARR KEVIN P | Director, 10% Owner | 16 | $0 | $0 | 2015-02-19 |
| Celgene European Investment Co LLC | 10% Owner | 2 | $38.29M | $0 | 2014-12-16 |
| TRV GP, LLC | 10% Owner | 3 | $0 | $0 | 2014-09-11 |
| ARCH Venture Partners VII, L.P. | 10% Owner | 1 | $0 | $0 | 2014-06-23 |
| AFEYAN NOUBAR | 10% Owner | 1 | $0 | $0 | 2014-06-23 |
| Flagship Ventures Fund 2007, L.P. | 10% Owner | 3 | $0 | $0 | 2013-07-29 |
| BYBEE CLINTON | 10% Owner | 3 | $0 | $0 | 2013-07-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-10-26 | 2026-10-28 | 7,866 | — | $0 | 16,275 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-10-26 | 2026-10-28 | 7,866 | $37.69 | $296.5K | 54,645 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2026-10-26 | 2026-10-28 | 7,866 | $25.01 | $196.7K | 62,511 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-10-22 | 2026-10-23 | 500 | — | $0 | 24,141 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-10-22 | 2026-10-23 | 500 | $37.52 | $18.8K | 54,645 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2026-10-22 | 2026-10-23 | 500 | $25.01 | $12.5K | 55,145 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-10-21 | 2026-10-23 | 1,489 | — | $0 | 24,641 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-10-21 | 2026-10-23 | 1,489 | $37.53 | $55.9K | 54,645 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2026-10-21 | 2026-10-23 | 1,489 | $25.01 | $37.2K | 56,134 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-08-04 | 2026-08-06 | 30,000 | $30.48 | $914.4K | 54,645 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-08-04 | 2026-08-06 | 30,000 | $30.48 | $914.4K | 54,645 | SEC↗ |
| Backstrom Jay T. | Director | M Exercise deriv | 2026-07-08 | 2026-07-10 | 1,447 | — | $0 | 2,894 | SEC↗ |
| Backstrom Jay T. | Director | A Award | 2026-07-08 | 2026-07-10 | 1,447 | — | $0 | 1,447 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-07-01 | 2026-07-02 | 8,375 | — | $0 | 0 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-07-01 | 2026-07-02 | 4,007 | $37.56 | $150.5K | 84,645 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2026-07-01 | 2026-07-02 | 8,375 | — | $0 | 88,652 | SEC↗ |
| Backstrom Jay T. | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| Backstrom Jay T. | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 9,000 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | A Award deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | A Award deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 9,000 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 9,000 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | A Award deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 9,000 | SEC↗ |
| Burns James William | Chief Legal Officer | A Award deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2026-06-18 | 2026-06-23 | 39,000 | — | $0 | 39,000 | SEC↗ |
| Goff Brian | Chief Executive Officer | A Award deriv | 2026-06-18 | 2026-06-23 | 39,000 | — | $0 | 39,000 | SEC↗ |
| Viswanadhan Krishnan | Chief Strategy and Operation | M Exercise deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 9,000 | SEC↗ |
| Viswanadhan Krishnan | Chief Strategy and Operation | A Award deriv | 2026-06-18 | 2026-06-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| Smith Cynthia | Director | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| Scadden David | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| Scadden David | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| Scadden David | Director | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| Owen Adams Catherine | Director | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| Owen Adams Catherine | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| Owen Adams Catherine | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| Ho Maykin | Director | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| FOUSE JACQUALYN A | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| FOUSE JACQUALYN A | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| FOUSE JACQUALYN A | Director | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| Foster-Cheek Kaye I | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| Foster-Cheek Kaye I | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| Foster-Cheek Kaye I | Director | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| CAPELLO JEFFREY D | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| CAPELLO JEFFREY D | Director | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| CAPELLO JEFFREY D | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| Ballal Rahul D. | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| Ballal Rahul D. | Director | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| Ballal Rahul D. | Director | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 15,230 | SEC↗ |
| Scadden David | Director | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 20,419 | SEC↗ |
| Owen Adams Catherine | Director | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 10,865 | SEC↗ |
| Ho Maykin | Director | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 19,848 | SEC↗ |
| FOUSE JACQUALYN A | Director | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 154,156 | SEC↗ |
| Foster-Cheek Kaye I | Director | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 10,284 | SEC↗ |
| CAPELLO JEFFREY D | Director | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 10,865 | SEC↗ |
| Ballal Rahul D. | Director | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 15,230 | SEC↗ |
| CAPELLO JEFFREY D | Director | M Exercise deriv | 2026-06-13 | 2026-06-16 | 1,976 | — | $0 | 0 | SEC↗ |
| Owen Adams Catherine | Director | M Exercise deriv | 2026-06-13 | 2026-06-16 | 1,976 | — | $0 | 0 | SEC↗ |
| CAPELLO JEFFREY D | Director | M Exercise | 2026-06-13 | 2026-06-16 | 1,976 | — | $0 | 8,049 | SEC↗ |
| Owen Adams Catherine | Director | M Exercise | 2026-06-13 | 2026-06-16 | 1,976 | — | $0 | 8,049 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2026-04-02 | 2026-04-06 | 25,528 | — | $0 | 0 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2026-04-02 | 2026-04-06 | 13,500 | — | $0 | 40,500 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | M Exercise deriv | 2026-04-02 | 2026-04-06 | 8,100 | — | $0 | 8,100 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise deriv | 2026-04-02 | 2026-04-06 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2026-04-02 | 2026-04-06 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-04-02 | 2026-04-06 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise deriv | 2026-04-02 | 2026-04-06 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2026-04-02 | 2026-04-06 | 13,500 | — | $0 | 191,104 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2026-04-02 | 2026-04-06 | 25,528 | — | $0 | 190,076 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2026-04-02 | 2026-04-06 | 6,596 | $34.71 | $228.9K | 184,508 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2026-04-02 | 2026-04-06 | 12,472 | $34.71 | $432.9K | 177,604 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | S Sale | 2026-04-02 | 2026-04-06 | 2,959 | $34.71 | $102.7K | 10,282 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | M Exercise | 2026-04-02 | 2026-04-06 | 8,100 | — | $0 | 13,241 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | S Sale | 2026-04-02 | 2026-04-06 | 3,262 | $34.71 | $113.2K | 46,829 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise | 2026-04-02 | 2026-04-06 | 8,500 | — | $0 | 50,091 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2026-04-02 | 2026-04-06 | 3,141 | $34.71 | $109.0K | 54,998 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise | 2026-04-02 | 2026-04-06 | 8,500 | — | $0 | 58,139 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-04-02 | 2026-04-06 | 2,940 | $34.71 | $102.0K | 80,277 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2026-04-02 | 2026-04-06 | 8,500 | — | $0 | 83,217 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2026-04-02 | 2026-04-06 | 3,280 | $34.71 | $113.8K | 49,306 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise | 2026-04-02 | 2026-04-06 | 8,500 | — | $0 | 52,586 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | M Exercise deriv | 2026-03-05 | 2026-03-09 | 8,100 | — | $0 | 16,200 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | M Exercise | 2026-03-05 | 2026-03-09 | 8,100 | — | $0 | 8,100 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | S Sale | 2026-03-05 | 2026-03-09 | 2,959 | $27.80 | $82.3K | 5,141 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | S Sale | 2026-03-03 | 2026-03-05 | 5,272 | $28.88 | $152.3K | 868 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 2,350 | — | $0 | 0 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 2,695 | — | $0 | 5,390 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 2,450 | — | $0 | 2,450 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 8,000 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 5,666 | — | $0 | 5,667 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 8,000 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 5,666 | — | $0 | 5,667 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 2,000 | — | $0 | 0 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 5,303 | — | $0 | 10,607 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 0 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 5,666 | — | $0 | 5,667 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 8,000 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 3,920 | — | $0 | 7,839 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 0 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 5,666 | — | $0 | 5,667 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 8,000 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 8,500 | — | $0 | 0 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2026-03-02 | 2026-03-03 | 13,000 | — | $0 | 26,000 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | M Exercise | 2026-03-02 | 2026-03-03 | 2,350 | — | $0 | 3,293 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | M Exercise | 2026-03-02 | 2026-03-03 | 2,450 | — | $0 | 4,970 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | S Sale | 2026-03-02 | 2026-03-03 | 798 | $28.96 | $23.1K | 6,140 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | M Exercise | 2026-03-02 | 2026-03-03 | 2,695 | — | $0 | 6,938 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | S Sale | 2026-03-02 | 2026-03-03 | 727 | $28.96 | $21.1K | 4,243 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | S Sale | 2026-03-02 | 2026-03-03 | 698 | $28.96 | $20.2K | 2,595 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,681 | $28.96 | $48.7K | 38,778 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise | 2026-03-02 | 2026-03-03 | 5,666 | — | $0 | 40,459 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 42,778 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,187 | $28.96 | $34.4K | 41,591 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise | 2026-03-02 | 2026-03-03 | 5,303 | — | $0 | 50,901 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,573 | $28.96 | $45.6K | 49,328 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise | 2026-03-02 | 2026-03-03 | 2,000 | — | $0 | 39,394 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-03 | 594 | $28.96 | $17.2K | 38,800 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise | 2026-03-02 | 2026-03-03 | 5,666 | — | $0 | 44,466 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,187 | $28.96 | $34.4K | 45,598 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,681 | $28.96 | $48.7K | 42,785 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 46,785 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 68,795 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,187 | $28.96 | $34.4K | 67,608 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2026-03-02 | 2026-03-03 | 5,666 | — | $0 | 73,274 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,681 | $28.96 | $48.7K | 71,593 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,187 | $28.96 | $34.4K | 74,406 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 75,593 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,163 | $28.96 | $33.7K | 44,086 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise | 2026-03-02 | 2026-03-03 | 3,920 | — | $0 | 45,249 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,187 | $28.96 | $34.4K | 41,329 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 42,516 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,681 | $28.96 | $48.7K | 38,516 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise | 2026-03-02 | 2026-03-03 | 5,666 | — | $0 | 40,197 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2026-03-02 | 2026-03-03 | 1,187 | $28.96 | $34.4K | 34,531 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise | 2026-03-02 | 2026-03-03 | 4,000 | — | $0 | 35,718 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2026-03-02 | 2026-03-03 | 13,000 | — | $0 | 170,466 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2026-03-02 | 2026-03-03 | 8,267 | $28.96 | $239.4K | 157,466 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2026-03-02 | 2026-03-03 | 18,000 | — | $0 | 165,733 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2026-03-02 | 2026-03-03 | 3,870 | $28.96 | $112.1K | 147,733 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2026-03-02 | 2026-03-03 | 8,500 | — | $0 | 151,603 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2026-03-02 | 2026-03-03 | 5,918 | $28.96 | $171.4K | 164,548 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | A Award deriv | 2026-03-01 | 2026-03-03 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | A Award deriv | 2026-03-01 | 2026-03-03 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 8,452 | — | $0 | 8,452 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Burns James William | Chief Legal Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Burns James William | Chief Legal Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Goff Brian | Chief Executive Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 174,000 | — | $0 | 174,000 | SEC↗ |
| Goff Brian | Chief Executive Officer | A Award deriv | 2026-03-01 | 2026-03-03 | 48,000 | — | $0 | 48,000 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise deriv | 2026-01-05 | 2026-01-07 | 8,475 | — | $0 | 0 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise | 2026-01-05 | 2026-01-07 | 8,475 | — | $0 | 37,665 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | S Sale | 2026-01-05 | 2026-01-07 | 2,872 | $27.02 | $77.6K | 34,793 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2025-12-30 | 2026-01-02 | 6,000 | — | $0 | 0 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise deriv | 2025-12-30 | 2026-01-02 | 6,000 | — | $0 | 0 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2025-12-30 | 2026-01-02 | 6,000 | — | $0 | 0 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2025-12-30 | 2026-01-02 | 25,528 | — | $0 | 25,528 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2025-12-30 | 2026-01-02 | 12,750 | — | $0 | 0 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise deriv | 2025-12-30 | 2026-01-02 | 6,000 | — | $0 | 0 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise | 2025-12-30 | 2026-01-02 | 6,000 | — | $0 | 40,326 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2025-12-30 | 2026-01-02 | 2,932 | $27.09 | $79.4K | 37,394 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | S Sale | 2025-12-30 | 2026-01-02 | 2,932 | $27.09 | $79.4K | 29,190 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise | 2025-12-30 | 2026-01-02 | 6,000 | — | $0 | 32,122 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2025-12-30 | 2026-01-02 | 6,000 | — | $0 | 67,727 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-12-30 | 2026-01-02 | 2,932 | $27.09 | $79.4K | 64,795 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2025-12-30 | 2026-01-02 | 6,230 | $27.09 | $168.8K | 143,103 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2025-12-30 | 2026-01-02 | 25,528 | — | $0 | 149,056 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2025-12-30 | 2026-01-02 | 12,473 | $27.09 | $337.9K | 136,583 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2025-12-30 | 2026-01-02 | 12,750 | — | $0 | 149,333 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise | 2025-12-30 | 2026-01-02 | 6,000 | — | $0 | 34,650 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2025-12-30 | 2026-01-02 | 2,932 | $27.09 | $79.4K | 31,718 | SEC↗ |
| Scadden David | Director | M Exercise deriv | 2025-11-12 | 2025-11-14 | 200 | — | $0 | 26,907 | SEC↗ |
| Scadden David | Director | S Sale | 2025-11-12 | 2025-11-14 | 200 | $43.84 | $8.8K | 17,603 | SEC↗ |
| Scadden David | Director | M Exercise | 2025-11-12 | 2025-11-14 | 200 | $18.09 | $3.6K | 17,803 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2025-11-11 | 2025-11-13 | 2,454 | — | $0 | 26,130 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-11-11 | 2025-11-13 | 2,454 | $43.78 | $107.4K | 61,727 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2025-11-11 | 2025-11-13 | 2,454 | $25.01 | $61.4K | 64,181 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2025-10-30 | 2025-11-03 | 200 | — | $0 | 28,584 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-10-30 | 2025-11-03 | 200 | $43.81 | $8.8K | 61,727 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2025-10-30 | 2025-11-03 | 200 | $25.01 | $5.0K | 61,927 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2025-10-27 | 2025-10-29 | 3,302 | — | $0 | 28,784 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2025-10-27 | 2025-10-29 | 3,302 | $25.01 | $82.6K | 65,029 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-10-27 | 2025-10-29 | 3,302 | $43.92 | $145.0K | 61,727 | SEC↗ |
| Scadden David | Director | M Exercise deriv | 2025-10-08 | 2025-10-10 | 200 | — | $0 | 27,107 | SEC↗ |
| Scadden David | Director | M Exercise | 2025-10-08 | 2025-10-10 | 200 | $18.09 | $3.6K | 17,803 | SEC↗ |
| Scadden David | Director | S Sale | 2025-10-08 | 2025-10-10 | 200 | $41.00 | $8.2K | 17,603 | SEC↗ |
| Scadden David | Director | M Exercise deriv | 2025-09-30 | 2025-10-02 | 200 | — | $0 | 27,307 | SEC↗ |
| Scadden David | Director | S Sale | 2025-09-30 | 2025-10-02 | 200 | $40.00 | $8.0K | 17,603 | SEC↗ |
| Scadden David | Director | M Exercise | 2025-09-30 | 2025-10-02 | 200 | $18.09 | $3.6K | 17,803 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2025-09-26 | 2025-09-30 | 7,472 | — | $0 | 0 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise | 2025-09-26 | 2025-09-30 | 7,472 | — | $0 | 37,521 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2025-09-26 | 2025-09-30 | 3,651 | $36.77 | $134.2K | 33,870 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | S Sale | 2025-09-05 | 2025-09-09 | 8,546 | $36.87 | $315.1K | 868 | SEC↗ |
| Scadden David | Director | M Exercise deriv | 2025-08-27 | 2025-08-29 | 200 | — | $0 | 27,507 | SEC↗ |
| Scadden David | Director | S Sale | 2025-08-27 | 2025-08-29 | 200 | $40.00 | $8.0K | 17,603 | SEC↗ |
| Scadden David | Director | M Exercise | 2025-08-27 | 2025-08-29 | 200 | $18.09 | $3.6K | 17,803 | SEC↗ |
| Smith Cynthia | Director | M Exercise deriv | 2025-08-11 | 2025-08-13 | 2,302 | — | $0 | 0 | SEC↗ |
| Ballal Rahul D. | Director | M Exercise deriv | 2025-08-11 | 2025-08-13 | 2,302 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | M Exercise | 2025-08-11 | 2025-08-13 | 2,302 | — | $0 | 12,414 | SEC↗ |
| Ballal Rahul D. | Director | M Exercise | 2025-08-11 | 2025-08-13 | 2,302 | — | $0 | 12,414 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2025-08-08 | 2025-08-12 | 22,691 | — | $0 | 0 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2025-08-08 | 2025-08-12 | 11,085 | $36.67 | $406.5K | 123,528 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2025-08-08 | 2025-08-12 | 22,691 | — | $0 | 134,613 | SEC↗ |
| Scadden David | Director | M Exercise deriv | 2025-07-10 | 2025-07-15 | 1,400 | — | $0 | 27,707 | SEC↗ |
| Scadden David | Director | M Exercise | 2025-07-10 | 2025-07-15 | 1,400 | $18.09 | $25.3K | 19,003 | SEC↗ |
| Scadden David | Director | S Sale | 2025-07-10 | 2025-07-15 | 1,400 | $40.00 | $56.0K | 17,603 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2025-07-09 | 2025-07-11 | 11,914 | — | $0 | 32,086 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2025-07-09 | 2025-07-11 | 11,914 | $25.01 | $298.0K | 73,185 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-07-09 | 2025-07-11 | 11,067 | $37.93 | $419.8K | 62,118 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-07-09 | 2025-07-11 | 847 | $38.76 | $32.8K | 61,271 | SEC↗ |
| Backstrom Jay T. | Director | A Award deriv | 2025-07-08 | 2025-07-10 | 4,341 | — | $0 | 4,341 | SEC↗ |
| Backstrom Jay T. | Director | A Award deriv | 2025-07-08 | 2025-07-10 | 23,393 | — | $0 | 23,393 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2025-07-01 | 2025-07-03 | 8,374 | — | $0 | 8,375 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-07-01 | 2025-07-03 | 4,091 | $34.17 | $139.8K | 61,271 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2025-07-01 | 2025-07-03 | 8,374 | — | $0 | 65,362 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2025-06-24 | 2025-06-26 | 12,750 | — | $0 | 12,750 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise deriv | 2025-06-24 | 2025-06-26 | 25,527 | — | $0 | 51,056 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise deriv | 2025-06-24 | 2025-06-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise deriv | 2025-06-24 | 2025-06-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise deriv | 2025-06-24 | 2025-06-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise deriv | 2025-06-24 | 2025-06-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2025-06-24 | 2025-06-26 | 25,527 | — | $0 | 117,872 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2025-06-24 | 2025-06-26 | 6,229 | $33.54 | $208.9K | 111,922 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2025-06-24 | 2025-06-26 | 12,471 | $33.54 | $418.3K | 105,401 | SEC↗ |
| Goff Brian | Chief Executive Officer | M Exercise | 2025-06-24 | 2025-06-26 | 12,750 | — | $0 | 118,151 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | S Sale | 2025-06-24 | 2025-06-26 | 2,770 | $33.54 | $92.9K | 26,122 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | M Exercise | 2025-06-24 | 2025-06-26 | 6,000 | — | $0 | 28,892 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2025-06-24 | 2025-06-26 | 1,780 | $33.54 | $59.7K | 30,049 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | M Exercise | 2025-06-24 | 2025-06-26 | 6,000 | — | $0 | 31,829 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | M Exercise | 2025-06-24 | 2025-06-26 | 6,000 | — | $0 | 59,897 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-06-24 | 2025-06-26 | 2,909 | $33.54 | $97.6K | 56,988 | SEC↗ |
| Burns James William | Chief Legal Officer | M Exercise | 2025-06-24 | 2025-06-26 | 6,000 | — | $0 | 31,449 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2025-06-24 | 2025-06-26 | 2,799 | $33.54 | $93.9K | 28,650 | SEC↗ |
| Smith Cynthia | Director | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| Scadden David | Director | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| Owen Adams Catherine | Director | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| Ho Maykin | Director | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| FOUSE JACQUALYN A | Director | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| Foster-Cheek Kaye I | Director | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| CAPELLO JEFFREY D | Director | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| Ballal Rahul D. | Director | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| Smith Cynthia | Director | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 10,112 | SEC↗ |
| Scadden David | Director | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 17,603 | SEC↗ |
| Owen Adams Catherine | Director | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 6,073 | SEC↗ |
| Ho Maykin | Director | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 17,032 | SEC↗ |
| FOUSE JACQUALYN A | Director | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 151,340 | SEC↗ |
| Foster-Cheek Kaye I | Director | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 7,468 | SEC↗ |
| CAPELLO JEFFREY D | Director | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 6,073 | SEC↗ |
| Ballal Rahul D. | Director | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 10,112 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| Scadden David | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| Scadden David | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| Owen Adams Catherine | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| Owen Adams Catherine | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| Ho Maykin | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| FOUSE JACQUALYN A | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| FOUSE JACQUALYN A | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| Foster-Cheek Kaye I | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| Foster-Cheek Kaye I | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| CAPELLO JEFFREY D | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| CAPELLO JEFFREY D | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 2,861 | — | $0 | 2,861 | SEC↗ |
| Ballal Rahul D. | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| Ballal Rahul D. | Director | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| Owen Adams Catherine | Director | M Exercise deriv | 2025-06-13 | 2025-06-17 | 1,977 | — | $0 | 1,976 | SEC↗ |
| CAPELLO JEFFREY D | Director | M Exercise deriv | 2025-06-13 | 2025-06-17 | 1,977 | — | $0 | 1,976 | SEC↗ |
| Owen Adams Catherine | Director | M Exercise | 2025-06-13 | 2025-06-17 | 1,977 | — | $0 | 3,953 | SEC↗ |
| CAPELLO JEFFREY D | Director | M Exercise | 2025-06-13 | 2025-06-17 | 1,977 | — | $0 | 3,953 | SEC↗ |
| FOUSE JACQUALYN A | Director | S Sale | 2025-04-10 | 2025-04-10 | 7,497 | $25.90 | $194.2K | 149,220 | SEC↗ |
| FOUSE JACQUALYN A | Director | M Exercise deriv | 2025-04-08 | 2025-04-10 | 15,933 | — | $0 | 0 | SEC↗ |
| FOUSE JACQUALYN A | Director | M Exercise | 2025-04-08 | 2025-04-10 | 15,933 | — | $0 | 156,717 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | A Award deriv | 2025-03-05 | 2025-03-07 | 55,374 | — | $0 | 55,374 | SEC↗ |
| Viswanadhan Krishnan | Chief Corp Dev & Strategy | A Award deriv | 2025-03-05 | 2025-03-07 | 24,300 | — | $0 | 24,300 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | M Exercise deriv | 2025-03-03 | 2025-03-04 | 2,450 | — | $0 | 4,900 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | S Sale | 2025-03-03 | 2025-03-04 | 231 | $35.54 | $8.2K | 6,038 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | S Sale | 2025-03-03 | 2025-03-04 | 727 | $35.54 | $25.8K | 9,414 | SEC↗ |
| Washburn Theodore James Jr. | Principal Accounting Officer | S Sale | 2025-03-03 | 2025-03-04 | 697 | $35.54 | $24.8K | 7,691 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-03-03 | 2025-03-04 | 1,681 | $35.54 | $59.7K | 53,897 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-03-03 | 2025-03-04 | 1,137 | $35.54 | $40.4K | 47,098 | SEC↗ |
| Gheuens Sarah | Chief Medical Officer | S Sale | 2025-03-03 | 2025-03-04 | 1,187 | $35.54 | $42.2K | 49,911 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-04 | 8,794 | $35.54 | $312.5K | 92,345 | SEC↗ |
| Goff Brian | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-04 | 4,153 | $35.54 | $147.6K | 83,139 | SEC↗ |
| Milanova Tsveta | Chief Commercial Officer | S Sale | 2025-03-03 | 2025-03-04 | 1,681 | $35.54 | $59.7K | 22,892 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2025-03-03 | 2025-03-04 | 594 | $35.54 | $21.1K | 21,843 | SEC↗ |
| Jones Cecilia | Chief Financial Officer | S Sale | 2025-03-03 | 2025-03-04 | 1,681 | $35.54 | $59.7K | 25,829 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2025-03-03 | 2025-03-04 | 1,681 | $35.54 | $59.7K | 25,449 | SEC↗ |
| Burns James William | Chief Legal Officer | S Sale | 2025-03-03 | 2025-03-04 | 1,137 | $35.54 | $40.4K | 18,650 | SEC↗ |